.

BioPharmaceutical Business Intelligence

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Fuji
AstraZeneca
Citi
McKesson
Teva
Medtronic
US Department of Justice
Harvard Business School
Fish and Richardson
UBS

Generated: February 18, 2018

DrugPatentWatch Database Preview

Suppliers and packages for generic ingredient: olsalazine sodium

« Back to Dashboard

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package
Mylan Speciality LpDIPENTUMolsalazine sodiumCAPSULE;ORAL019715NDAMEDA PharmaceuticalsN0037-6860-10
Mylan Speciality LpDIPENTUMolsalazine sodiumCAPSULE;ORAL019715NDACarilion Materials ManagementN68151-0312-1
Mylan Speciality LpDIPENTUMolsalazine sodiumCAPSULE;ORAL019715NDACarilion Materials ManagementN68151-3120-1
Mylan Speciality LpDIPENTUMolsalazine sodiumCAPSULE;ORAL019715NDAAlaven Pharmaceutical LLCE68220-160-10
This preview shows a limited number of results
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Farmers Insurance
QuintilesIMS
Harvard Business School
US Department of Justice
Fish and Richardson
Chinese Patent Office
Cerilliant
Fuji
McKesson
Merck

Copyright 2002-2018 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot